Search results for Tezepelumab

Tezepelumab Biosimilar – Anti-TSLP mAb – Research Grade, ProteoGenix, PX-TA1399

Description of Tezepelumab Biosimilar - Anti-TSLP mAb - Research Grade General information on Anti-TSLP[Homo sapiens] (Tezepelumab) Monoclonal Antibody Tezepelumab is investigated in the treatment of Oral Corticosteroid Dependent Asthma.

Tezepelumab, Kyinno, KB-1311

Tezepelumab, Abbexa, abx831358

Tezepelumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TSLP, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Tezepelumab is under investigation in clinical trial NCT03406078 (Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma).

Tezepelumab ELISA Kit, ProteoGenix, KPTX270

Description of Tezepelumab ELISA Kit The Structure of Tezepelumab ELISA Kit Tezepelumab ELISA Kit is a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) kit designed for the detection of Tezepelumab, a human monoclonal antibody targeting thymic stromal lymphopoietin (TSLP). TSLP is a cytokine that plays a crucial role in the initiation and amplification of allergic and inflammatory responses. Tezepelumab is a promising therapeutic agent for the treatment of various inflammatory and allergic diseases, including asthma, atopic dermatitis, and chronic obstructive pulmonary disease (COPD). The Tezepelumab ELISA Kit is composed of several components, including a microplate coated with a monoclonal antibody specific to Tezepelumab, a biotinylated detection antibody, streptavidin-HRP conjugate, and TMB substrate solution. The Tezepelumab-specific monoclonal antibody is immobilized on the surface of the microplate, providing a solid support for the detection of Tezepelumab. The biotinylated detection antibody recognizes a different epitope on Tezepelumab and is used to capture the target antibody in a sandwich ELISA format. The streptavidin-HRP conjugate binds to the biotinylated detection antibody, and the resulting complex is detected by the addition of the TMB substrate solution, which produces a colorimetric signal proportional to the amount of Tezepelumab present in the sample. The Activity of Tezepelumab ELISA Kit The Tezepelumab ELISA Kit has been validated for its sensitivity, specificity, precision, and linearity. It has a detection limit of 0.1 ng/mL and can accurately measure Tezepelumab concentrations ranging from 0.156 ng/mL to 10 ng/mL. The kit has a high specificity for Tezepelumab and does not cross-react with other related cytokines or therapeutic antibodies. The intra- and inter-assay coefficients of variation are less than 10%, indicating a high level of precision and reproducibility. The standard curve generated by the Tezepelumab ELISA Kit is linear and has a correlation coefficient of 0.99, demonstrating the accuracy and reliability of the assay. The Tezepelumab ELISA Kit is designed to be user-friendly and time-efficient, with a total assay time of only 2.5 hours. The kit can be used with a variety of sample types, including serum, plasma, and cell culture supernatant. It is suitable for both research and clinical applications, providing a valuable tool for the evaluation of Tezepelumab levels in patient samples. The Application of Tezepelumab ELISA Kit Tezepelumab ELISA Kit has a wide range of applications in the field of immunology and drug development. It is a valuable tool for the quantification of Tezepelumab levels in preclinical and clinical studies, allowing for the evaluation of pharmacokinetics and pharmacodynamics of the therapeutic antibody. The Tezepelumab ELISA Kit can also be used to monitor the efficacy of Tezepelumab treatment in patients with allergic and inflammatory diseases. It can provide valuable insights into the mechanism of action of Tezepelumab and its potential role in modulating the immune response. Furthermore, the Tezepelumab ELISA Kit can be used in the development and quality control of Tezepelumab-based therapeutics. It can accurately measure the concentration of Tezepelumab in drug formulations and ensure the consistency and potency of the product. The kit can also be used to screen and select high-affinity Tezepelumab clones during the development of new therapeutic antibodies targeting TSLP.

Tezepelumab ELISA Kit, Abbexa, abx395159

Tezepelumab ELISA Kit is a quantitative ELISA kit for detection of Tezepelumab.Tezepelumab is a first-in-class human monoclonal antibody that binds to TSLP, thus inhibiting its interaction with TSLP receptor complex. Tezepelumab given as an add-on-therapy to patients with severe uncontrolled asthma has shown safety, tolerability and efficacy. Several trials are evaluating the long-term safety and the efficacy of tezepelumab in adults and adolescents with severe uncontrolled asthma.

Tezepelumab Biosimilar - Research Grade, ichor.bio, ICH5213

Detects TSLP

Research Grade Tezepelumab (HV243016), abinScience, HV243016